De uiteindelijke resultaten van het onderzoek worden door middel van publicaties in medische tijdschriften openbaar gemaakt. Hieronder ziet u een lijst met publicaties door EURAP.
2009
Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry.
Eurap Study Group.
Epilepsia. 2009 Oct;50(10):2305-9. Epub 2009 May 12.
PMID: 19453723 [PubMed - indexed for MEDLINE]
2007Neural tube defects associated with prenatal exposure to antiepilpetic drugs.Flipsen-ten Berg K, van Oppen ACC, Wentges-van Holthe JML, Schielen PCJI, Lambrechts DAJE, Galjaard RJ, Lindhout D. Reprod Toxicol 2007;24(1):60-61.
2006
Outcomes of human pregnancies after levetiracetam exposure.
ten Berg K, van Oppen ACC, van Donselaar CA, Wentges-van Holthe JM, Koppe WM, Tamminga P, Lindhout D. Birth Defects Res A Clin Mol Teratol 2006;76(5):318.
Status epilepticus in pregnancy.
Battino D, Bonizzoni E, Craig J, Lindhout D, Perruca E, Sabers A, Tomson T, Vajda F. Epilepsia 2006;47(S3):26-27.
How well are neural tube defects diagnosed prenatally when the mother is taking antiepileptic drugs?
ten Berg K, Brink EJM, van Donselaar CA, van Oppen ACC, Schielen PCJI, Lindhout D. Epilepsia 2006;47(S3):118.
EURAP Germany: Seizure control and dose modifications during pregancy under treatment with valproate, carabamazepine, and lamotrigine in monotherapy.
Gaus V, Coban I, Kretz R, Schmitz B. Epilepsia 2006;47(S3):125.
EURAP: A registry of antiepileptic drugs and pregnancy and an example of a european collaborative initiative.
Tomson T. Epilepsia 2006:47(S3):229-230.
Seizure control and treatment in pregnancy: observations from the EURAP Epilepsy Pregnancy Registry.
The EURAP Study Group. Neurology 2006;66:354–60.
2005
Update from EURAP.
Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Tomson T, Vajda F. Epilepsia 2005;46(Suppl 6):40.
Levetiracetam: clinical experience in human pregnancy.
ten Berg K, van Donselaar CA, van Oppen ACC, Lindhout D. Reprod Toxicol 2005;20(3):453.
Levetiracetam use and pregnancy outcome.
ten Berg K, Samrén EB, Van Oppen ACC, Engelsman M, Lindhout D. Reprod Toxicol 2005;20:175–8.
Complex cardiac defect with hypoplastic right ventricle in a fetus with valproate exposure.
ten Berg K, Van Oppen ACC, Nikkels PGJ, Gittenberger-de Groot AC, van der Voet GB, Brilstra EH, Lindhout D. Prenat Diagn 2005;25:156-8.
2004
Anti-epileptica en aangeboren afwijkingen: Betere voorlichting aan vrouwen met epilepsie noodzakelijk.
ten Berg K, Van Donselaar CA, Van Oppen ACC, Lindhout D. Medisch Contact 2004;43:1697-9.
EURAP: an international registry of antiepileptic drugs and pregnancy.
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Vajda F; Collaborative EURAP Study Group. Epilepsia 2004;45(11):1463-4.
Congenital abnormalities in maternal epilepsy treated with lamotrigine-valproate combination: clinical assessment of a phenotype.
ten Berg K, Veenstra-Knol HE, van Pinxteren-Nagler E, Engström LJ, Lindhout D. Reprod Toxicol 2004;18(5):721-2.
Complex heart malformation after prenatal exposure to valproate.
ten Berg K, Nikkels PGJ, Gittenberger-de Groot AC, van der Voet GB, Lindhout D, Van Oppen ACC, Brilstra EH. Genetic Counseling 2004;15(1):135-6.
2002
Concordance as well as discordance for congenital malformations in valproate-exposed half-siblings with parental consanguinity may indicate a specific gene-teratogen interaction.
ten Berg K, Lindhout D. Clin Dysmorphol 2002;11(3):227-8.
2001
Antiepileptic drugs in pregnancy: options for the prevention of congenital abnormalities.
ten Berg K, Lindhout D. Community Genet 2002;5(1):40-9.
EURAP: An International Pregnancy Registry for the Evaluation of the Comparative Teratogenic Effects of Antiepileptic Drugs.
Tomson T, Battino D, Beausart M, et al. Epilepsia 2001;42(Suppl 7):293.